Precision Medicine in Oncology

The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move t...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2019
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (163 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02302nam-a2200397z--4500
001 993548697104498
005 20231214133315.0
006 m o d
007 cr|mn|---annan
008 202102s2019 xx |||||o ||| 0|eng d
035 |a (CKB)4920000000094081 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/56871 
035 |a (EXLCZ)994920000000094081 
041 0 |a eng 
100 1 |a Andrea Lunardi  |4 auth 
245 1 0 |a Precision Medicine in Oncology 
260 |b Frontiers Media SA  |c 2019 
300 |a 1 electronic resource (163 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
520 |a The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration. 
546 |a English 
653 |a computational biology 
653 |a synthetic biology 
653 |a pathology 
653 |a noncoding RNA 
653 |a aberration 
653 |a precision medicine 
653 |a in vivo preclinical platform 
653 |a oncology 
776 |z 2-88945-705-2 
700 1 |a Angela Re  |4 auth 
700 1 |a Caterina Nardella  |4 auth 
700 1 |a Alessandro Quattrone  |4 auth 
906 |a BOOK 
ADM |b 2023-12-15 05:49:56 Europe/Vienna  |f system  |c marc21  |a 2019-11-10 04:18:40 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338851680004498&Force_direct=true  |Z 5338851680004498  |b Available  |8 5338851680004498